Merit Medical Systems, Inc.

Merit Medical Systems, Inc.

MMSI
Merit Medical Systems, Inc.US flagNASDAQ Global Select
90.76
USD
+0.26
- -
5.42BMarket Cap
Merit Medical Systems, Inc.
MMSI
(NASDAQ Global Select)

Recent

price

90.76

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.41
9.2
9.35
10.54
11.81
12.31
13.6
14.91
16.89
18.06
17.39
19.14
20.26
21.83
23.3
25.62
26.56
Revenue per Share
0.35
0.59
0.47
0.39
0.53
0.54
0.45
0.56
0.8
0.1
-0.18
0.86
1.31
1.64
2.07
2.17
2.45
Basic EPS, GAAP
0.28
-0.7
1.11
1.21
1.24
1.58
1.21
1.29
1.66
1.41
2.98
2.62
2.01
2.52
3.79
5.03
4.77
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
6.64
8.5
8.98
9.47
9.98
10.53
11.16
13.46
16.99
17.21
17.23
18.38
19.97
20.78
23.48
26.66
28.13
Book Value per Share
3.37
5.7
2.08
2.36
3.22
3.89
2.32
4.2
2.45
2.74
4.08
6.34
8.88
8.54
7.11
9.08
8.84
Tangible Book Value per Share
35
39
42
43
43
44
44
49
52
55
55
56
57
58
58
59
59
Basic Weighted Avg Shares
297
359
394
449
510
542
604
728
883
995
964
1,075
1,151
1,257
1,357
1,516
1,579
Sales/Revenue/Turnover
8.61
10.86
8.14
7.09
7.98
7.12
5.86
6.28
6.71
3.97
4.76
7.29
8.78
10.14
11.51
12.25
12.74
Operating Margin (%)
15
19
23
33
36
37
44
54
70
104
107
96
92
101
115
135
136
Depreciation Expense
12
23
20
17
23
24
20
28
42
5
-10
48
75
94
120
128
146
Net Income, GAAP
25.78
29.9
28.63
16.48
27.23
23.71
20.74
23.29
15.15
- -
- -
10.13
9.82
15.77
19.76
24.83
25.15
Effective Tax Rate (%)
4.2
6.41
5
3.69
4.51
4.39
3.33
3.78
4.76
0.55
-1.02
4.51
6.47
7.51
8.87
8.48
9.22
Profit Margin (%)
72
90
89
100
117
116
155
201
254
273
245
246
308
905
707
800
847
Working Capital
83
31
228
239
214
198
314
259
373
505
415
296
246
879
784
811
809
LT Debt
236
357
382
406
435
466
498
676
933
950
959
1,040
1,144
1,202
1,379
1,584
1,680
Total Equity
6.96
7.71
4.52
4.16
4.48
4.39
3.74
3.94
4.4
- -
- -
5.14
6.6
6.13
5.89
6.11
6.27
Return on Invested Capital (%)
4.74
6.68
4
3.66
4.47
4.28
3.62
3.76
4.45
- -
- -
3.87
5.8
6.13
6.81
6.48
7.04
Return on Capital (%)
5.48
7.78
5.34
4.21
5.46
5.28
4.17
4.69
5.22
0.58
-1.03
4.85
6.82
8.05
9.33
8.67
9.19
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
11
11
LT Borrowings
734
735
736
LT Finance Leases
77
75
73
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
59
60
60
Market Capitalization
5,238
4,112
4,140

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,040
1,102
1,112
Cash, Cash Equivalents & STI
446
488
449
Accounts Receivable, Net
204
206
224
Inventories
334
352
374
Total Current Liabilities
240
217
265
Payables & Accruals
229
206
254
ST Debt
11
11
11
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.65%
10.64%
14.86%
Free Cash Flow
21.5%
16.1%
34.68%
Net Income, GAAP
-77.12%
-95.51%
6.76%
Sales/Revenue/Turnover
11.03%
9.49%
11.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
324
338
340
355
1,357
2025
355
382
384
394
1,516
2026
382
419
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.49
0.61
0.49
0.48
2.07
2025
0.51
0.55
0.47
0.64
2.17
2026
0.69
0.65
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Merit Medical Systems, Inc. is a leading worldwide designer, developer, manufacturer, and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987 and headquartered in South Jordan, Utah, the company operates in two primary segments, Cardiovascular and Endoscopy, offering a broad portfolio of products including micropuncture kits, angiographic needles, sheaths, guidewires, safety devices, inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, thrombolytic catheters, fluid dispensing systems, angiography accessories, hemostatic solutions, and procedural kits for peripheral intervention, spine, and oncology applications; it serves hospitals, physicians, and clinicians globally with approximately 7,000 employees and manufacturing facilities worldwide. In May 2025, Merit acquired Biolife Delaware, L.L.C. for approximately $120 million in cash and assumed liabilities, adding the patented StatSeal and WoundSeal hemostatic products that address a $350 million global market opportunity and are projected to contribute $18 million in annual revenue starting in fiscal 2026; earlier transactions include the November 2024 acquisition of assets from Cook Medical Holdings LLC and the July 2024 acquisition of EndoGastric Solutions, Inc., alongside a signed asset purchase agreement in October 2025 for the C2 CryoBalloon from PENTAX Medical to expand its gastroenterology portfolio.

Company News

APIChatGPT
  • Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage

  • Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum

  • Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript

  • COO vs. MMSI: Which Stock Should Value Investors Buy Now?

  • Merit Medical to Participate in Upcoming Investors Conferences in August

  • MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised

  • These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

  • Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript

  • Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates

  • Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

  • Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?

  • Allspring Global Investments Holdings LLC Sells 32,413 Shares of Merit Medical Systems, Inc. $MMSI

  • MMSI vs. WST: Which Stock Should Value Investors Buy Now?

  • Here's Why Merit Medical (MMSI) is a Strong Growth Stock

  • Here's Why Merit Medical (MMSI) is a Strong Value Stock

  • Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

  • Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

  • MMSI or WST: Which Is the Better Value Stock Right Now?

  • Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term